Sugarbaker, P. H., & Van der Speeten, K. (2021). Peritoneal progression after pancreaticoduodenectomy is a devastating surgical treatment failure: HIPEC gemcitabine is an option. J Gastrointest Oncol.
Citação norma ChicagoSugarbaker, Paul H., and Kurt Van der Speeten. "Peritoneal Progression After Pancreaticoduodenectomy Is a Devastating Surgical Treatment Failure: HIPEC Gemcitabine Is an Option." J Gastrointest Oncol 2021.
Deismireacht MLASugarbaker, Paul H., and Kurt Van der Speeten. "Peritoneal Progression After Pancreaticoduodenectomy Is a Devastating Surgical Treatment Failure: HIPEC Gemcitabine Is an Option." J Gastrointest Oncol 2021.
Rabhadh: D'fhéadfadh nach mbeadh na deismireachtaí seo 100% cruinn i gcónaí.